Encompass Health Corporation
Price
FilingsNewest: 13G, Stake over 5%, passiveAug 14 →InsidersNo open-market buys. 4 insiders sold $21.4M, 0 of 12 sales on a 10b5-1 plan.→HoldersBlackRock 9.0%Vanguard Portfolio 4.2%Vanguard 3.9%→PeersClosest companies: HCA, CYH, THC→
From the filings
Figures
- Revenue
- $6.21Blast 12 months
- Net income
- $621.0Mlast 12 months
- Operating cash flow
- $1.20Blast 12 months
- Cash and equivalents
- $107.7Mat the last balance sheet
- Total debt
- $2.63Bat the last balance sheet
- Shares outstanding
- 116.0M shareson issue